SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-001247
Filing Date
2024-02-15
Accepted
2024-02-15 16:45:30
Documents
17
Period of Report
2024-02-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agrx-20240209x8k.htm   iXBRL 8-K 50615
2 EX-10.1 agrx-20240209xex10d1.htm EX-10.1 29409
3 EX-99.1 agrx-20240209xex99d1.htm EX-99.1 16304
  Complete submission text file 0001558370-24-001247.txt   250620

Data Files

Seq Description Document Type Size
4 EX-101.SCH agrx-20240209.xsd EX-101.SCH 3435
5 EX-101.LAB agrx-20240209_lab.xml EX-101.LAB 18738
6 EX-101.PRE agrx-20240209_pre.xml EX-101.PRE 12862
18 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20240209x8k_htm.xml XML 4810
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 24644479
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)